100 related articles for article (PubMed ID: 9689978)
1. Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy.
Green SL; Giaccia AJ
Cancer J Sci Am; 1998; 4(4):218-23. PubMed ID: 9689978
[No Abstract] [Full Text] [Related]
2. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells.
Alarcón T; Byrne HM; Maini PK
J Theor Biol; 2004 Aug; 229(3):395-411. PubMed ID: 15234206
[TBL] [Abstract][Full Text] [Related]
3. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
Denko NC; Green SL; Edwards D; Giaccia AJ
Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
[TBL] [Abstract][Full Text] [Related]
4. Role of ribonucleotide reductase in regulation of cell cycle progression during and after exposure to moderate hypoxia.
Graff P; Amellem O; Andersson KK; Pettersen EO
Anticancer Res; 2002; 22(1A):59-68. PubMed ID: 12017335
[TBL] [Abstract][Full Text] [Related]
5. Biological consequences of tumor hypoxia.
Höckel M; Vaupel P
Semin Oncol; 2001 Apr; 28(2 Suppl 8):36-41. PubMed ID: 11395851
[TBL] [Abstract][Full Text] [Related]
6. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
10. Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells.
Alqawi O; Wang HP; Espiritu M; Singh G
Free Radic Res; 2007 Jul; 41(7):788-97. PubMed ID: 17577739
[TBL] [Abstract][Full Text] [Related]
11. Effects of hypoxia on tumor metabolism.
Kim JW; Gao P; Dang CV
Cancer Metastasis Rev; 2007 Jun; 26(2):291-8. PubMed ID: 17415528
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cell death in the tumor microenvironment.
Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
[TBL] [Abstract][Full Text] [Related]
13. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
[TBL] [Abstract][Full Text] [Related]
14. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies.
Martinive P; Defresne F; Bouzin C; Saliez J; Lair F; Grégoire V; Michiels C; Dessy C; Feron O
Cancer Res; 2006 Dec; 66(24):11736-44. PubMed ID: 17178869
[TBL] [Abstract][Full Text] [Related]
17. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
[TBL] [Abstract][Full Text] [Related]
19. [Tumor dormancy therapy--what do you think of this therapy?].
Sasaki T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):1949-54. PubMed ID: 11791373
[TBL] [Abstract][Full Text] [Related]
20. To proliferate or to divide - to be or not to be.
Genbacev O
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):63-4. PubMed ID: 11753517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
